Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver

Herpes Simplex Virus Oncolytic Therapy for Pediatric Malignancies

(2009) Gregory K Friedman et al.   MOLECULAR THERAPY

Cancer, stem cells, and oncolytic viruses

(2008) Camilla Ribacka et al.   ANNALS OF MEDICINE

The role of salvage treatment in advanced colorectal cancer

(2008) Jaume Capdevila et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Non-Engineered, Naturally Oncolytic Herpes Simplex Virus HSV1 HF-10:Applications for Cancer Gene Therapy

(2008) Akihiro Nawa et al.   CURRENT GENE THERAPY

Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy

(2008) Kaitlyn J Kelly et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Use of oncolytic viruses for the eradication of drug-resistant cancer cells

(2008) D. Wodarz   Journal of the Royal Society Interface

Immunotherapeutic potential of oncolytic virotherapy

(2008) Robin J Prestwich et al.   LANCET ONCOLOGY

A Herpes Oncolytic Virus Can Be Delivered Via the Vasculature to Produce Biologic Changes in Human Colorectal Cancer

(2008) Yuman Fong et al.   MOLECULAR THERAPY

Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM

(2008) James M Markert et al.   MOLECULAR THERAPY